Unichem Laboratories Limited

Equities

UNICHEMLAB

INE351A01035

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:48 2024-04-19 am EDT 5-day change 1st Jan Change
577.8 INR -1.32% Intraday chart for Unichem Laboratories Limited +6.69% +42.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Unichem Laboratories Limited Announces Board Resignations, Effective March 31, 2024 CI
Unichem Laboratories Chief Commercial and International Business Development Officer Steps Down MT
Unichem Laboratories Limited Announces Resignation of Santosh Mahil as Chief Commercial & International Business Development Officer CI
Unichem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Indian Equities Close Marginally Higher Ahead of IT Earnings MT
Unichem Laboratories Gets US FDA Approval for Generic Hypertension Drug MT
Unichem Laboratories Limited Receives Anda Approval for Its Doxazosin Tablets USP, 1 Mg, 2 Mg, 4 Mg and 8 Mg CI
Unichem Laboratories Completes Sale of Entire Stake in Optimus Drugs MT
Unichem Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Ipca Laboratories Limited completed the acquisition of 19.29% stake in Unichem Laboratories Limited for INR 6 billion. CI
Unichem Laboratories Gets US FDA Nod for Prasugrel Tablets MT
Unichem Laboratories Limited Receives ANDA Approval for its Prasugrel Tablets USP, 5 Mg and 10 Mg from the United States Food and Drug Administration CI
Unichem Laboratories Limited Announces the Resignation of Dilip Kunkolienkar as Member of the Audit Committee and Risk Management Committee of the Board of Directors CI
Ipca Laboratories Acquires 33% Stake in Unichem for INR9.45 Billion MT
Unichem Laboratories Trims Consolidated Net Loss in Fiscal Q1 MT
Unichem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Unichem Laboratories Swings to Loss in Fiscal Q4 MT
Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Transcript : Ipca Laboratories Limited, Unichem Laboratories Limited - M&A Call
Ipca Laboratories to Acquire 33% Stake in Unichem for INR10.3 Billion MT
INDIA STOCKS-Indian shares flat ahead of key earnings; IT, pharma stocks slide RE
INDIA STOCKS-Indian shares flat ahead of key earnings; IT, pharma stocks fall RE
India's Ipca Laboratories sinks to 3-yr low after Unichem Lab deal RE
Indian pharma Ipca Labs to buy over 33% stake in Unichem RE
Ipca Laboratories Limited made an offer to acquire a 26% stake in Unichem Laboratories Limited for INR 8 billion CI
Chart Unichem Laboratories Limited
More charts
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
More about the company
  1. Stock Market
  2. Equities
  3. UNICHEMLAB Stock
  4. News Unichem Laboratories Limited
  5. Unichem Laboratories Gets US FDA Approval for Generic Mental Disorder Drug